Fig. 3
From: NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses
Prognostic value of NOX4 across tumors. (A) Overall survival (OS), (B) Disease-specific survival (DSS), (C, D) GEPIA2.0 analysis of the impact of NOX4 expression on overall survival (C) and disease-free survival (D) in TCGA pan-cancer.
